-
1
-
-
0035835818
-
p16(MTS-1/CDKN2/INK4a) in cancer progression
-
DOI 10.1006/excr.2000.5149
-
Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res, 2001, 264:42-55. (Pubitemid 32989080)
-
(2001)
Experimental Cell Research
, vol.264
, Issue.1
, pp. 42-55
-
-
Rocco, J.W.1
Sidransky, D.2
-
2
-
-
77950675075
-
p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma
-
Taghavi N, Biramijamal F, Sotoudeh M, et al. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer, 2010, 10:138.
-
(2010)
BMC Cancer
, vol.10
, pp. 138
-
-
Taghavi, N.1
Biramijamal, F.2
Sotoudeh, M.3
-
3
-
-
0036732023
-
Modes of silencing of p16 in development of esophageal squamous cell carcinoma
-
Tokugawa T, Sugihara H, Tani T, et al. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res, 2002, 62:4938-4944. (Pubitemid 34984417)
-
(2002)
Cancer Research
, vol.62
, Issue.17
, pp. 4938-4944
-
-
Tokugawa, T.1
Sugihara, H.2
Tani, T.3
Hattori, T.4
-
4
-
-
60549100565
-
Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus
-
Kim YT, Park JY, Jeon YK, et al. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus. Dis Esophagus, 2009, 22:143-150.
-
(2009)
Dis Esophagus
, vol.22
, pp. 143-150
-
-
Kim, Y.T.1
Park, J.Y.2
Jeon, Y.K.3
-
5
-
-
27144449574
-
DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage
-
DOI 10.1111/j.1349-7006.2005.00082.x
-
Mizuiri H, Yoshida K, Toge T, et al. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci, 2005, 96:571-577. (Pubitemid 41488420)
-
(2005)
Cancer Science
, vol.96
, Issue.9
, pp. 571-577
-
-
Mizuiri, H.1
Yoshida, K.2
Toge, T.3
Oue, N.4
Aung, P.P.5
Noguchi, T.6
Yasui, W.7
-
6
-
-
0038756374
-
Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma
-
Kuroki T, Trapasso F, Yendamuri S, et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res, 2003, 63:3724-3728. (Pubitemid 36793058)
-
(2003)
Cancer Research
, vol.63
, Issue.13
, pp. 3724-3728
-
-
Kuroki, T.1
Trapasso, F.2
Yendamuri, S.3
Matsuyama, A.4
Alder, H.5
Mori, M.6
Croce, C.M.7
-
7
-
-
51649127815
-
CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma
-
Lee EJ, Lee BB, Han J, et al. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma. Int J Cancer, 2008, 123:2073-2079.
-
(2008)
Int J Cancer
, vol.123
, pp. 2073-2079
-
-
Lee, E.J.1
Lee, B.B.2
Han, J.3
-
8
-
-
84892593422
-
-
Chinese source
-
-
-
-
9
-
-
49049107355
-
Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients
-
Ayadi W, Karray-Hakim H, Khabir A, et al. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients. Anticancer Res, 2008, 28:2161-2167.
-
(2008)
Anticancer Res
, vol.28
, pp. 2161-2167
-
-
Ayadi, W.1
Karray-Hakim, H.2
Khabir, A.3
-
10
-
-
84892605299
-
-
Chinese source
-
-
-
-
11
-
-
70450247231
-
Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: A high-risk area
-
Salam I, Hussain S, Mir MM, et al. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Mol Cell Biochem, 2009, 332:51-58.
-
(2009)
Mol Cell Biochem
, vol.332
, pp. 51-58
-
-
Salam, I.1
Hussain, S.2
Mir, M.M.3
-
12
-
-
33750687509
-
Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma
-
Fukuoka T, Hibi K, Nakao A. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma. Anticancer Res, 2006, 26:3333-3335. (Pubitemid 44701505)
-
(2006)
Anticancer Research
, vol.26
, Issue.5 A
, pp. 3333-3335
-
-
Fukuoka, T.1
Hibi, K.2
Nakao, A.3
-
13
-
-
84892604981
-
-
Chinese source
-
-
-
-
14
-
-
84892577792
-
-
Chinese source
-
-
-
-
15
-
-
0024420298
-
Neoplastic characteristics of the DNA found in the plasma of cancer patients
-
Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology, 1989, 46:318-322. (Pubitemid 19216753)
-
(1989)
Oncology
, vol.46
, Issue.5
, pp. 318-322
-
-
Stroun, M.1
Anker, P.2
Maurice, P.3
Lyautey, J.4
Lederrey, C.5
Beljanski, M.6
-
16
-
-
0035866393
-
DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells
-
Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res, 2001, 61:1659-1665. (Pubitemid 34292602)
-
(2001)
Cancer Research
, vol.61
, Issue.4
, pp. 1659-1665
-
-
Jahr, S.1
Hentze, H.2
Englisch, S.3
Hardt, D.4
Fackelmayer, F.O.5
Hesch, R.-D.6
Knippers, R.7
-
17
-
-
77949577362
-
DNA-based assay for EPHB6 expression in breast carcinoma cells as a potential diagnostic test for detecting tumor cells in circulation
-
Fox BP, Kandpal RP. DNA-based assay for EPHB6 expression in breast carcinoma cells as a potential diagnostic test for detecting tumor cells in circulation. Cancer Genomics Proteomics, 2010, 7:9-16.
-
(2010)
Cancer Genomics Proteomics
, vol.7
, pp. 9-16
-
-
Fox, B.P.1
Kandpal, R.P.2
-
18
-
-
0029843950
-
Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
-
DOI 10.1073/pnas.93.18.9821
-
Herman JG, Graff JR, Myohänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996, 93:9821-9826. (Pubitemid 26296693)
-
(1996)
Proceedings of the National Academy of Sciences of the United States of America
, vol.93
, Issue.18
, pp. 9821-9826
-
-
Herman, J.G.1
Graff, J.R.2
Myohanen, S.3
Nelkin, B.D.4
Baylin, S.B.5
-
19
-
-
1842535279
-
2-expression is linked to aberrant methylation in esophageal squamous-cell carcinoma cell lines
-
Liu ZM, Ding F, Guo MZ, et al. Downregulation of retinoic acid receptor-beta(2) expression is linked to aberrant methylation in esophageal squamous cell carcinoma cell lines. World J Gastroenterol, 2004, 10:771-775. (Pubitemid 38418344)
-
(2004)
World Journal of Gastroenterology
, vol.10
, Issue.6
, pp. 771-775
-
-
Liu, Z.-M.1
Ding, F.2
Guo, M.-Z.3
Zhang, L.-Y.4
Wu, M.5
Liu, Z.-H.6
-
20
-
-
0034741236
-
Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues
-
Zhang W, Rashid A, Wu H, et al. Differential expression of retinoic acid receptors and p53 protein in normal, premalignant, and malignant esophageal tissues. J Cancer Res Clin Oncol, 2001, 127:237-242.
-
(2001)
J Cancer Res Clin Oncol
, vol.127
, pp. 237-242
-
-
Zhang, W.1
Rashid, A.2
Wu, H.3
-
21
-
-
84892604821
-
-
Chinese source
-
-
-
-
22
-
-
84892571754
-
-
Chinese source
-
-
-
-
23
-
-
68649085640
-
Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome
-
Hoffmann AC, Vallböhmer D, Prenzel K, et al. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J Cancer Res Clin Oncol, 2009, 135:1231-1237.
-
(2009)
J Cancer Res Clin Oncol
, vol.135
, pp. 1231-1237
-
-
Hoffmann, A.C.1
Vallböhmer, D.2
Prenzel, K.3
|